ModelEdge
Moonlake Immunotherapeutics
MLTX
Filing type
S-3ASR
Filing date
Aug 9, 2026
Updated
Aug 10, 2026 ยท 2:37 PM

Filing

S-3ASRS-3ASR

Exhibits

EX-1.3AMENDMENT NO. 1 TO SALES AGREEMENT, BY AND BETWEEN MOONLAKE IMMUNOTHERAPEUTICS AND LEERINK PARTNERS LLC, DATED AUGUST 10, 2026EX-4.1FORM OF INDENTURE FOR SENIOR DEBT SECURITIES AND THE RELATED FORM OF SENIOR DEBT SECURITYEX-4.2FORM OF INDENTURE FOR SUBORDINATED DEBT SECURITIES AND RELATED FORM OF SUBORDINATED DEBT SECURITYEX-5.1OPINION OF WALKERS (CAYMAN) LLPEX-5.2OPINION OF WALKERS (CAYMAN) LLPEX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMEX-FILING FEESFILING FEE TABLEGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic